Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of AZD8309 on LPS-Induced Airway Inflammation in Healthy Volunteers
2005-002584-90Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AZD8309 sequence arm with Placebo sequence arm (2 arms). Primary endpoint: Neutrophil numbers in induced sputum after inhaled LPS. Started Jun 2005; status: completed.
02
Drugs
AZD8309
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-002584-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002584-90.